100
Views
24
CrossRef citations to date
0
Altmetric
Review

FGF-1: a human growth factor in the induction of neoangiogenesis

Pages 2011-2015 | Published online: 03 Mar 2005

Bibliography

  • FOLKMAN J, KLAGSBRUN M: Angiogenic factors. Science (1987) 235:442–447.
  • •One of the basic publications on the principles of angio-genesis, and a good survey of growth factors with angio-genic efficacy.
  • BURGESS WH, MACIAG T: The heparin-binding (fibro-blast) growth factor family of proteins. Ann. Res. Bio-chem. (1989) 58:575–606.
  • FOLKMAN J: Tumor angiogenesis: therapeutic implica-tions. New Engl. J. Med. (1971) 285:1182–1186.
  • FOLKMAN J, SHING Y: Angiogenesis. J. Biol. Chem. (1992) 267:10931–10934.
  • BANAI S, JAKLITSCH M, CASSCELLS W et al: Effects ofacidic fibroblast growth factor on normal and ischemic myo-cardium. Circ. Res. (1991) 69:76–85.
  • YANAGISAWA-MIWA A, UCHIDA Y, NAKAMURA F et al:Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science (1992) 257:1401–1402.
  • •First study of experimental testing of the effects of intracoro-nary basic FGF following induction of acute myocardial in-farction in dogs.
  • BATTLER A, SCHEINOWITZ M, BOR A et al: Intracoro- nary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocar-dium. J. Am. Coll Cardiol (1993) 22:2001–2006.
  • BANAI S, SHWEIKI D, PINSON A et al.: Up-regulation of vascular endothelial growth factor expression in-duced by myocardial ischemia: implications for coro-nary angiogenesis. Cardiovasc. Res. (1994) 28:1176–1179.
  • PEARLMAN J, HIBBERD M, CHUANG M et al.: Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med. (1995) 1:1085–1089.
  • SELLKE F, LI J, STAMLER A et al.: Angiogenesis inducedby acidic fibroblast growth factor as an alternative method of revascularisation for chronic myocardial ischemia. Surgery (1996) 120:182–188.
  • •Experimental study on the efficacy of acidic FGF to normal-ise vasomotor regulation and to improve myocardial perfu-sion in chronic myocardial ischemia.
  • MACK C, MAGOVERN C, BUDENBENDER K et al.: Salvageangiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J. Vasc. Surg. (1998) 27:699–709.
  • ISNER JM, WALSH K, SYMES J eta].: Arterial gene therapyfor therapeutic angiogenesis in patients with periph-eral vascular disease. Circulation (1995) 91:2687–2692.
  • ISNER JM, PIECZEK A, SCHAINFELD R et al: Clinical evi-dence of angiogenesis after arterial gene transfer of phVEGFiss in patient with ischaemic limb. Lancet (1996) 348:370–374.
  • ••First report of clinical application of gene-mediated angio-genic therapy in a patient with critically ischaemic limb.
  • SCHUMACHER B, PECHER P, V. SPECHT BU, STEGMANN TH: Induction of neoangiogenesis in ischemic myocar-dium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation (1998) 97:645–650.
  • ••The first report of angiogenic therapy of human coronaryheart disease. Evidence of increased myocardial neovascu-larisation following intramyocardial injection of FGF-1.
  • BAUMGARTNER I, PIECZEK A, MANOR O et al: Constitu- tive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in pa-tients with critical limb ischemia. Circulation (1998) 97:1114–1123.
  • ••Report of a first clinical trial of intramuscular gene transfer ofnaked plasmid DNA encoding the 165-amino-acid isoform of VEGF in 9 patients with 10 critically ischaemic limbs.
  • SELLKE FW, LAHAM RJ, EDELMAN ER et al.: Therapeuticangiogenesis with basic fibroblast growth factor: tech-nique and early results. Ann. Thorac. Surg. (1998) 65:1540–1544.
  • SCHUMACHER B, PECHER P, SPECHT BU, STEGMANN TH:The stimulation of neoangiogenesis in the ischemic heart by the human growth factor FGF. J. Cardiovasc. Surg. (In Press.)
  • •Demonstration of not only the angiogenic efficacy but also the exclusion of oncogenic and pyrogenic effects of human FGF-1 by experimental research.
  • SCHUMACHER B, PECHER P, SPECHT BU, STEGMANN TH: The stimulation of neoangiogenesis in the ischemic human heart by the growth factor FGF: first clinical re-sults. J. Cardiovasc. Surg. (In Press.)
  • WARE JA, SIMONS M: Angiogenesis in ischemic heart disease. Nature Med. (1997) 3:158–164.
  • •Survey of the results of experimental research in the field of angiogenesis; also a look to further developments and de-mands of study design in clinical application of angiogenic therapy.
  • REKHTER MD, SIMARI RD, WORK CW et al: Gene transfer into normal and atherosclerotic human blood vessels. Circ. Res. (1998) 82:1243–1252.
  • FOLKMAN J: Clinical applications of research on angio-genesis. New Engl. J. Med. (1995) 333:1757–1763.
  • NABEL EG, YANG ZY, PLAUTZ G et al.: Recombinant fi-broblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Na-ture (1993) 362:844–846.
  • THOMAS KA: Vascular endothelial growth factor, a po-tent and selective angiogenic agent. J. Biol. Chem. (1996) 271:603–606.
  • WALTENBERGER J, MAYR U, PENTZ S, HOMBACH V: Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation (1996) 94:1647–1654.
  • FOLKMAN J: Therapeutic angiogenesis in ischemiclimbs (Editorial). Circulation (1998) 97:1108–1110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.